Report Detail
Global Osteoarthritis Gene Therapy Market Growth (Status and Outlook) 2022-2028
- RnM4398794 |
- 15 March, 2022 |
- Global |
- 102 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of Osteoarthritis Gene Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Osteoarthritis Gene Therapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Osteoarthritis Gene Therapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Osteoarthritis Gene Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Osteoarthritis Gene Therapy market, reaching US$ million by the year 2028. As for the Europe Osteoarthritis Gene Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Osteoarthritis Gene Therapy players cover Flexion, GeneQuine, Novartis, and Smith & Nephew, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Gene Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Synovium Injection
Cartilage Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals and clinics
Orthopedic Centers
Assisted living Facilities
Nursing Homes
Ambulatory Surgical Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Flexion
GeneQuine
Novartis
Smith & Nephew
Genascence
Kolon TissueGene
Sanofi
Paraxel
Medipost
Mundipharma
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Osteoarthritis Gene Therapy Market Size 2017-2028
- 2.1.2 Osteoarthritis Gene Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Osteoarthritis Gene Therapy Segment by Type
- 2.2.1 Synovium Injection
- 2.2.2 Cartilage Injection
- 2.3 Osteoarthritis Gene Therapy Market Size by Type
- 2.3.1 Osteoarthritis Gene Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Osteoarthritis Gene Therapy Market Size Market Share by Type (2017-2022)
- 2.4 Osteoarthritis Gene Therapy Segment by Application
- 2.4.1 Hospitals and clinics
- 2.4.2 Orthopedic Centers
- 2.4.3 Assisted living Facilities
- 2.4.4 Nursing Homes
- 2.4.5 Ambulatory Surgical Centers
- 2.4.6 Others
- 2.5 Osteoarthritis Gene Therapy Market Size by Application
- 2.5.1 Osteoarthritis Gene Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Osteoarthritis Gene Therapy Market Size Market Share by Application (2017-2022)
3 Osteoarthritis Gene Therapy Market Size by Player
- 3.1 Osteoarthritis Gene Therapy Market Size Market Share by Players
- 3.1.1 Global Osteoarthritis Gene Therapy Revenue by Players (2020-2022)
- 3.1.2 Global Osteoarthritis Gene Therapy Revenue Market Share by Players (2020-2022)
- 3.2 Global Osteoarthritis Gene Therapy Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Osteoarthritis Gene Therapy by Regions
- 4.1 Osteoarthritis Gene Therapy Market Size by Regions (2017-2022)
- 4.2 Americas Osteoarthritis Gene Therapy Market Size Growth (2017-2022)
- 4.3 APAC Osteoarthritis Gene Therapy Market Size Growth (2017-2022)
- 4.4 Europe Osteoarthritis Gene Therapy Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Osteoarthritis Gene Therapy Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Osteoarthritis Gene Therapy Market Size by Country (2017-2022)
- 5.2 Americas Osteoarthritis Gene Therapy Market Size by Type (2017-2022)
- 5.3 Americas Osteoarthritis Gene Therapy Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Osteoarthritis Gene Therapy Market Size by Region (2017-2022)
- 6.2 APAC Osteoarthritis Gene Therapy Market Size by Type (2017-2022)
- 6.3 APAC Osteoarthritis Gene Therapy Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Osteoarthritis Gene Therapy by Country (2017-2022)
- 7.2 Europe Osteoarthritis Gene Therapy Market Size by Type (2017-2022)
- 7.3 Europe Osteoarthritis Gene Therapy Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Osteoarthritis Gene Therapy by Region (2017-2022)
- 8.2 Middle East & Africa Osteoarthritis Gene Therapy Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Osteoarthritis Gene Therapy Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Osteoarthritis Gene Therapy Market Forecast
- 10.1 Global Osteoarthritis Gene Therapy Forecast by Regions (2023-2028)
- 10.1.1 Global Osteoarthritis Gene Therapy Forecast by Regions (2023-2028)
- 10.1.2 Americas Osteoarthritis Gene Therapy Forecast
- 10.1.3 APAC Osteoarthritis Gene Therapy Forecast
- 10.1.4 Europe Osteoarthritis Gene Therapy Forecast
- 10.1.5 Middle East & Africa Osteoarthritis Gene Therapy Forecast
- 10.2 Americas Osteoarthritis Gene Therapy Forecast by Country (2023-2028)
- 10.2.1 United States Osteoarthritis Gene Therapy Market Forecast
- 10.2.2 Canada Osteoarthritis Gene Therapy Market Forecast
- 10.2.3 Mexico Osteoarthritis Gene Therapy Market Forecast
- 10.2.4 Brazil Osteoarthritis Gene Therapy Market Forecast
- 10.3 APAC Osteoarthritis Gene Therapy Forecast by Region (2023-2028)
- 10.3.1 China Osteoarthritis Gene Therapy Market Forecast
- 10.3.2 Japan Osteoarthritis Gene Therapy Market Forecast
- 10.3.3 Korea Osteoarthritis Gene Therapy Market Forecast
- 10.3.4 Southeast Asia Osteoarthritis Gene Therapy Market Forecast
- 10.3.5 India Osteoarthritis Gene Therapy Market Forecast
- 10.3.6 Australia Osteoarthritis Gene Therapy Market Forecast
- 10.4 Europe Osteoarthritis Gene Therapy Forecast by Country (2023-2028)
- 10.4.1 Germany Osteoarthritis Gene Therapy Market Forecast
- 10.4.2 France Osteoarthritis Gene Therapy Market Forecast
- 10.4.3 UK Osteoarthritis Gene Therapy Market Forecast
- 10.4.4 Italy Osteoarthritis Gene Therapy Market Forecast
- 10.4.5 Russia Osteoarthritis Gene Therapy Market Forecast
- 10.5 Middle East & Africa Osteoarthritis Gene Therapy Forecast by Region (2023-2028)
- 10.5.1 Egypt Osteoarthritis Gene Therapy Market Forecast
- 10.5.2 South Africa Osteoarthritis Gene Therapy Market Forecast
- 10.5.3 Israel Osteoarthritis Gene Therapy Market Forecast
- 10.5.4 Turkey Osteoarthritis Gene Therapy Market Forecast
- 10.5.5 GCC Countries Osteoarthritis Gene Therapy Market Forecast
- 10.6 Global Osteoarthritis Gene Therapy Forecast by Type (2023-2028)
- 10.7 Global Osteoarthritis Gene Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Flexion
- 11.1.1 Flexion Company Information
- 11.1.2 Flexion Osteoarthritis Gene Therapy Product Offered
- 11.1.3 Flexion Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Flexion Main Business Overview
- 11.1.5 Flexion Latest Developments
- 11.2 GeneQuine
- 11.2.1 GeneQuine Company Information
- 11.2.2 GeneQuine Osteoarthritis Gene Therapy Product Offered
- 11.2.3 GeneQuine Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 GeneQuine Main Business Overview
- 11.2.5 GeneQuine Latest Developments
- 11.3 Novartis
- 11.3.1 Novartis Company Information
- 11.3.2 Novartis Osteoarthritis Gene Therapy Product Offered
- 11.3.3 Novartis Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Novartis Main Business Overview
- 11.3.5 Novartis Latest Developments
- 11.4 Smith & Nephew
- 11.4.1 Smith & Nephew Company Information
- 11.4.2 Smith & Nephew Osteoarthritis Gene Therapy Product Offered
- 11.4.3 Smith & Nephew Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Smith & Nephew Main Business Overview
- 11.4.5 Smith & Nephew Latest Developments
- 11.5 Genascence
- 11.5.1 Genascence Company Information
- 11.5.2 Genascence Osteoarthritis Gene Therapy Product Offered
- 11.5.3 Genascence Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Genascence Main Business Overview
- 11.5.5 Genascence Latest Developments
- 11.6 Kolon TissueGene
- 11.6.1 Kolon TissueGene Company Information
- 11.6.2 Kolon TissueGene Osteoarthritis Gene Therapy Product Offered
- 11.6.3 Kolon TissueGene Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Kolon TissueGene Main Business Overview
- 11.6.5 Kolon TissueGene Latest Developments
- 11.7 Sanofi
- 11.7.1 Sanofi Company Information
- 11.7.2 Sanofi Osteoarthritis Gene Therapy Product Offered
- 11.7.3 Sanofi Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Sanofi Main Business Overview
- 11.7.5 Sanofi Latest Developments
- 11.8 Paraxel
- 11.8.1 Paraxel Company Information
- 11.8.2 Paraxel Osteoarthritis Gene Therapy Product Offered
- 11.8.3 Paraxel Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Paraxel Main Business Overview
- 11.8.5 Paraxel Latest Developments
- 11.9 Medipost
- 11.9.1 Medipost Company Information
- 11.9.2 Medipost Osteoarthritis Gene Therapy Product Offered
- 11.9.3 Medipost Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Medipost Main Business Overview
- 11.9.5 Medipost Latest Developments
- 11.10 Mundipharma
- 11.10.1 Mundipharma Company Information
- 11.10.2 Mundipharma Osteoarthritis Gene Therapy Product Offered
- 11.10.3 Mundipharma Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Mundipharma Main Business Overview
- 11.10.5 Mundipharma Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Osteoarthritis Gene Therapy. Industry analysis & Market Report on Osteoarthritis Gene Therapy is a syndicated market report, published as Global Osteoarthritis Gene Therapy Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Osteoarthritis Gene Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
